Expand ADTX Menu
ADTX MENU

ADTX Latest Press Releases

-- April 2, 2024 --

Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) Business Wire 8:30 AM
Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc. Globe Newswire 7:30 AM

-- March 27, 2024 --

Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 PRNewswire 8:36 AM

-- March 20, 2024 --

Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal PRNewswire 8:54 AM

-- March 7, 2024 --

For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy PRNewswire 7:54 AM

-- February 1, 2024 --

Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023 PRNewswire 8:00 AM

-- January 30, 2024 --

Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap and NeuroEEG for Telehealth and Tele-neurology Applications Business Wire 8:30 AM

-- January 8, 2024 --

Aditxt, Inc.'s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.'s Proprietary Mitomic Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million Business Wire 8:30 AM

-- January 5, 2024 --

Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules Business Wire 8:30 AM

-- January 2, 2024 --

Aditxt, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement Business Wire 8:30 AM

-- December 29, 2023 --

Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules Business Wire 5:07 PM

-- December 14, 2023 --

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, ADTX, EVFM Globe Newswire 1:23 AM

-- December 12, 2023 --

ADTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aditxt, Inc. Is Fair to Shareholders Business Wire 9:53 AM
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally Business Wire 8:30 AM